Markel Group Inc (MKL)

NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-10-23

$1870.09-1.85%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Markel Group Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	3.8B
EPS	—	28.115
Annual ending 2026-12-31
Revenue	—	15.35B
EPS	—	94.659
Annual ending 2027-12-31
Revenue	—	15.26B
EPS	—	112.716

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
free cash flow yield	The company has beaten earnings estimates recently and has a strong free cash flow yield of 9%.	Intact	free cash flow yield falls below 7%	Free cash flow yield: 9% As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 20269 percent · calculatedLast status assessment Oct 24, 2026 Measurement source consolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: MKL:2026-10-23. Source status: canonical calculation. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
executive leadership stability	A supporting condition in Markel Group Inc's published investment case. The stated target is no major unexpected executive departures.	Under Pressure	unexpected departure of CEO or CFO	Qualitative: CEO transition (Sep 2026) & COO departure (Feb 2026) vs no unexpected departures COO Michael Heaton left in Feb 2026; CEO transition announced Sep 2026 with named successor. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
earnings per share (EPS) level	A primary condition in Markel Group Inc's published investment case. The stated target is EPS >= $116.49 in FY27.	Broken	EPS falls below $107 in FY26 or fails to reach $116.49 in FY27	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
total company revenue growth	A primary condition in Markel Group Inc's published investment case. The stated target is >=6.9% CAGR over next 3 years.	Broken	revenue growth falls below ~2% per year over next 3 years	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$112.72

$116.96 → $112.72 · observed estimates

FY2027 revenueUnavailable

$15.90B → Unavailable · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$116.96	$15,900,503,800	6 / 5
2026-07-25	$119.59	Unavailable	5 / 4
2026-07-26	$116.96	$15,900,503,800	6 / 5
2026-07-27	$119.59	Unavailable	5 / 4
2026-07-28	$116.96	$15,900,503,800	6 / 5
2026-07-29	$119.59	Unavailable	5 / 4
2026-07-30	$119.59	Unavailable	5 / 4
2026-07-31	$117.02	$15,897,537,600	6 / 5
2026-08-01	$114.01	Unavailable	5 / 4
2026-08-02	$114.75	$15,912,580,600	6 / 5
2026-08-03	$114.75	$15,912,580,600	6 / 5
2026-08-04	$114.01	Unavailable	5 / 4
2026-08-05	$114.75	$15,912,580,600	6 / 5
2026-08-06	$114.01	Unavailable	5 / 4
2026-08-07	$114.01	Unavailable	5 / 4
2026-08-08	$114.01	Unavailable	5 / 4
2026-08-09	$113.94	$15,929,380,600	6 / 5
2026-08-10	$114.01	Unavailable	5 / 4
2026-08-12	$113.94	$15,929,380,600	6 / 5
2026-08-13	$114.01	Unavailable	5 / 4
2026-08-14	$114.01	Unavailable	5 / 4
2026-08-15	$114.01	Unavailable	5 / 4
2026-08-16	$114.01	Unavailable	5 / 4
2026-08-17	$114.01	Unavailable	5 / 4
2026-08-18	$114.01	Unavailable	5 / 4
2026-08-19	$114.01	Unavailable	5 / 4
2026-08-20	$112.20	Unavailable	5 / 4
2026-08-21	$112.20	Unavailable	5 / 4
2026-08-22	$112.20	Unavailable	5 / 4
2026-08-23	$112.20	Unavailable	5 / 4
2026-08-24	$112.20	Unavailable	5 / 4
2026-08-25	$112.20	Unavailable	5 / 4
2026-08-26	$112.20	Unavailable	5 / 4
2026-08-27	$112.20	Unavailable	5 / 4
2026-08-28	$112.20	Unavailable	5 / 4
2026-08-29	$112.20	Unavailable	5 / 4
2026-08-30	$112.20	Unavailable	5 / 4
2026-08-31	$112.20	Unavailable	5 / 4
2026-09-01	$112.20	Unavailable	5 / 4
2026-09-02	$112.20	Unavailable	5 / 4
2026-09-03	$112.20	Unavailable	5 / 4
2026-09-04	$112.20	Unavailable	5 / 4
2026-09-05	$112.20	Unavailable	5 / 4
2026-09-06	$112.20	Unavailable	5 / 4
2026-09-07	$112.20	Unavailable	5 / 4
2026-09-08	$112.20	Unavailable	5 / 4
2026-09-09	$112.20	Unavailable	5 / 4
2026-09-10	$112.20	Unavailable	5 / 4
2026-09-11	$112.20	Unavailable	5 / 4
2026-09-12	$112.20	Unavailable	5 / 4
2026-09-13	$112.20	Unavailable	5 / 4
2026-09-14	$112.20	Unavailable	5 / 4
2026-09-15	$112.20	Unavailable	5 / 4
2026-09-16	$112.20	Unavailable	5 / 4
2026-09-17	Unavailable	Unavailable	4 / 4
2026-09-18	Unavailable	Unavailable	4 / 4
2026-09-19	Unavailable	Unavailable	4 / 4
2026-09-20	Unavailable	Unavailable	4 / 4
2026-09-21	Unavailable	Unavailable	4 / 4
2026-09-22	Unavailable	Unavailable	4 / 4
2026-09-23	Unavailable	Unavailable	4 / 4
2026-09-24	Unavailable	Unavailable	4 / 4
2026-09-25	Unavailable	Unavailable	4 / 4
2026-09-26	Unavailable	Unavailable	4 / 4
2026-09-27	Unavailable	Unavailable	4 / 4
2026-09-28	Unavailable	Unavailable	4 / 4
2026-09-29	Unavailable	Unavailable	4 / 4
2026-09-30	Unavailable	Unavailable	4 / 4
2026-10-01	Unavailable	Unavailable	4 / 4
2026-10-02	$112.20	Unavailable	5 / 4
2026-10-03	$112.20	Unavailable	5 / 4
2026-10-04	$112.20	Unavailable	5 / 4
2026-10-05	$112.20	Unavailable	5 / 4
2026-10-06	$112.20	Unavailable	5 / 4
2026-10-07	$112.16	Unavailable	5 / 4
2026-10-08	$112.16	Unavailable	5 / 4
2026-10-09	$112.16	Unavailable	5 / 4
2026-10-10	$112.16	Unavailable	5 / 4
2026-10-11	Unavailable	Unavailable	4 / 4
2026-10-12	Unavailable	Unavailable	4 / 4
2026-10-13	Unavailable	Unavailable	4 / 4
2026-10-14	Unavailable	Unavailable	4 / 4
2026-10-15	$112.72	Unavailable	5 / 4
2026-10-16	$112.72	Unavailable	5 / 4
2026-10-17	$112.72	Unavailable	5 / 4
2026-10-18	$112.72	Unavailable	5 / 4
2026-10-19	$112.72	Unavailable	5 / 4
2026-10-20	$112.72	Unavailable	5 / 4
2026-10-21	$112.72	Unavailable	5 / 4
2026-10-22	$112.72	Unavailable	5 / 4
2026-10-23	$112.72	Unavailable	5 / 4
2026-10-24	$112.72	Unavailable	5 / 4

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	0	6	0
2026-06-01	0	6	0
2026-07-01	0	6	1
2026-08-01	0	6	1
2026-09-01	0	6	1
2026-10-01	1	6	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 6 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

free cash flow yieldFree cash flow yield: 9%
executive leadership stabilityPublished status: Under Pressure
earnings per share (EPS) levelPublished status: Broken
total company revenue growthPublished status: Broken

Next proof point

Nov 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.6%Typical daily move · historical

Downside history

-21.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Markel Group Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

MKL is a financially oriented business with a multi-year thesis tied to underwriting profitability and organic growth, rather than a turnaround story. Management priorities are largely on track, but recent performance has lagged its industry cohort and confidence in the thesis has eased to medium.

What's priced into Markel Group Inc

The valuation is described as cheap versus peers, and the priced-in assessment is justified, with low fragility. The expectations gap is slightly negative, suggesting expectations are not especially demanding, though the valuation evidence does not remove the execution and sector risks.

What the fundamentals likely do

Near term, underwriting profitability and revenue growth have shown progress: the combined ratio has been around 93–97%, and recent revenue and operating income improved between the first and second quarters of 2026. However, MKL missed its most recent quarter and has a run of consecutive earnings misses, while the Financials sector is a headwind; capital discipline remains a watch item.

What Markel Group Inc hinges on

Over the next one to three years, the thesis hinges on management sustaining profitable underwriting and organic growth while maintaining capital discipline. Near term, lower rates could weigh on the sector, while continued earnings strength from CB, PGR, and TRV could support sector momentum; misses or weaker guidance from those peers could remove that support.